Home > Insider Trading > Filing (0001571049-17-004902)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601343	K Gerald Carlson	300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666-6712		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2017-05-09	50	$11.83	50	No	4	M	Direct
Class A Common Stock	Acquisiton	2017-05-09	10,239	$11.83	10,289	No	4	M	Direct
Class A Common Stock	Disposition	2017-05-09	10,289	$32.09	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-05-10	43,713	$11.83	43,713	No	4	M	Direct
Class A Common Stock	Disposition	2017-05-10	43,713	$33.55	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-05-11	9,336	$11.83	9,336	No	4	M	Direct
Class A Common Stock	Disposition	2017-05-11	9,336	$33.52	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2017-05-09	50	$0.00	50	$11.83
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2017-05-09	10,239	$0.00	10,239	$11.83
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2017-05-10	43,713	$0.00	43,713	$11.83
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2017-05-11	9,336	$0.00	9,336	$11.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-04-29	2019-02-28	No	4	M	Direct
67,111	2014-04-29	2019-02-28	No	4	M	Direct
23,398	2014-04-29	2019-02-28	No	4	M	Direct
14,062	2014-04-29	2019-02-28	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.60, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $34.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.75, inclusive.